The drug is being developed by the Chinese biotech Abbisko Therapeutics Co. Merck KGaA holds commercial license for Pimicotinib in Chinese mainland, Hong Kong, Macau, and Taiwan, it said.

with very low rates of discontinuation due to treatment-related adverse events Pimicotinib is being developed by Abbisko Therapeutics Co., Ltd.; Merck holds commercial license for pimicotinib in ...

Results from the study, which focused on gynecological malignant tumors, were presented at the Society for Immunotherapy of ...

Pivotal Phase 3 trial (IOB-013/KN-D18) evaluating off-the-shelf therapeutic cancer vaccine IO102-IO103 in combination with Merck’s anti-PD-1 ...

Companies with a long history of paying dividends and consistently hiking them remain appealing to income-focused investors.

Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course ...

Global Head of Bio4C Commercial, Merck, Singapore * Rajesh Krishnamurthy, Chief Executive Officer, Laurus Bio * Tine Rorvik, ...

Eric has held commercial leadership roles in large and small pharmaceutical companies in the US, Canada, and Switzerland. Over his 20-year tenure at Merck & Co., Inc., Eric helped to integrate ...

CureVac Announces Financial Results for the Third Quarter and First Nine Months of 2024 and Provides Business Update. Strengthened Cash, Strategic Refocus and Pipeline Progress De ...

Earlier in his career, he served as CFO at multiple publicly-traded biotech companies including Sirna Therapeutics, a genetic ...

Merck is one of the oldest companies in the ... The AI effect in pharma commercial strategy: From data to re... Discover how AI is transforming the pharma commercial strategy.

"In the third quarter, we delivered strong commercial results, maintained financial discipline, and... Trinity Capital Inc. ("Trinity"), a leading provider of diversified financial solutions to growth ...